Bonala et al. [8] reported that myostatin can promote insulin receptor substrate 1 (IRS1) protein degradation, and thus weakening the activation of insulin signaling pathways, and subsequently resulting in insulin resistance. The gene discussed is IRS1; the disease is Insulin resistance.